Latest JAK inhibitor trials for severe skin disease are a success
A new study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug.
Mar 28, 2022
0
205
A new study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug.
Mar 28, 2022
0
205
Spironolactone use is not associated with an increased risk for cancer, according to a systematic review and meta-analysis published online Feb. 9 in JAMA Dermatology.
Feb 23, 2022
0
15
You look in the mirror and notice you're going bald. It's a reality that many men must face.
Jan 17, 2022
0
2
(HealthDay)—For patients with alopecia areata (AA), treatment with an inhibitor of janus kinase (JAK)3 and the tyrosine kinase expressed in the hepatocellular carcinoma kinase family, ritlecitinib, and an inhibitor of tyrosine ...
Dec 8, 2021
0
2
(HealthDay)—Persistent chemotherapy-induced alopecia is more severe in patients who receive a taxane-containing chemotherapy for breast cancer, but a significant proportion of patients see improvement in hair density with ...
Sep 29, 2021
0
2
(HealthDay)—Androgenetic alopecia is associated with moderate impairment of health-related quality of life (HRQOL) and emotions, according to a review published online July 7 in JAMA Dermatology.
Jul 12, 2021
0
2
It's long been known that COVID-19 is more fatal for men than women, and new research links some of that excess risk to a gene known to cause a form of hair loss in males.
May 7, 2021
3
225
Tofacitinib, a Janus kinase inhibitor approved to treat rheumatoid arthritis and bowel diseases, may allow patients with celiac disease to eat gluten without experiencing intestinal and extraintestinal symptoms. A case report ...
Jul 28, 2020
0
4
The short answer is yes, stress and hair loss can be related.
Feb 10, 2020
0
5
(HealthDay)—Hairstyles are a defining feature for many people, but some 'dos can also damage hair follicles.
Feb 1, 2019
0
2